stock
XLO · Xilio Therapeutics, Inc.
What Xilio Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live XLO price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on XLO.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 5,782,511 as of 2026-03-18 (XBRL frame CY2026Q1I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -48.9%
- Net
- -34.1%
Returns
- ROE
- -30.2%
- ROA
- -14.2%
Health
- Current ratio
- 4.3x
- Debt/equity
- —
Deep value
- NCAV
- $63.48M
- NCAV per share
- $10.98
- Price/NCAV
- Locked
- NNWC
- $54.05M
- NNWC per share
- $9.35
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $18.69M | —Gross profit: unreported by this company. | -$3.49M | -$6.37M | 10-Q filed 2026-08-12 |
| 2026-03-31 | $12.65M | —Gross profit: unreported by this company. | -$14.11M | -$9.53M | 10-Q filed 2026-05-12 |
| 2025-12-31 | $13.69M | —Gross profit: unreported by this company. | -$11.84M | $10.36M | 10-K filed 2026-03-23 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $19.07M | —Gross profit: unreported by this company. | -$1.93M | -$16.29M | 10-Q filed 2025-11-13 |
| 2025-06-30 | $8.08M | —Gross profit: unreported by this company. | -$14.37M | -$15.84M | 10-Q filed 2026-08-12 |
| 2025-03-31 | $2.93M | —Gross profit: unreported by this company. | -$13.85M | -$13.27M | 10-Q filed 2026-05-12 |
| 2024-12-31 | — | —Gross profit: unreported by this company. | -$13.63M | -$13.09M | 10-K filed 2026-03-23 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $2.26M | —Gross profit: unreported by this company. | -$14.76M | -$14.02M | 10-Q filed 2025-11-13 |
- Assets
- $154.25M
- Equity
- $72.26M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $43.77M | -$41.98M | -$35.04M | -$5.51M |
| 2024-12-31 | $6.34M | -$60.58M | -$58.24M | -$18.41M |
| 2023-12-31 | — | -$79.13M | -$76.40M | -$69.11M |
| 2022-12-31 | — | -$89.15M | -$88.22M | -$77.59M |
| 2021-12-31 | — | -$75.04M | -$75.80M | -$81.85M |
| 2020-12-31 | — | -$54.56M | -$55.22M | -$38.28M |
Company filings
since Wed May 27 · 2 offering filings in 12 months · since Thu Feb 12
events
Results
ResultsAug 128-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 128-KResults
ResultsMay 128-KExecutive or director change
Executive or director changeApr 168-KResults
ResultsMar 238-KShareholder rights changed, Bylaws or fiscal year change
Shareholder rights changedBylaws or fiscal year changeMar 128-K
5% owners ()
StemPoint Capital LP
Stake update
ORBIMED ADVISORS LLC
Passive stake
BCLS II Equity Opportunities, LP
Stake update
Point72 Asset Management, L.P.
Stake update
Sirenia Capital Management LP
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named XLO, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about XLO.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on XLO come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the XLO board